Tafinlar/Mekinist Combination Benefits BRAF V600E/K Mutation-Positive Melanoma Patients June 18, 2015Vol.38 No.06
Adding Imbruvica to Bendamustine/Rituximab Combination Increases PFS in Phase III Leukemia Trial June 18, 2015Vol.38 No.06
Drugs & Targets FDA Grants Orphan Designation for Reolysin in Malignant Glioma June 01, 2015Vol.38 No.05
APD403 Demonstrates Control of Nausea and Vomiting after Highly Emetogenic Chemotherapy June 01, 2015Vol.38 No.05
MPDL3280A Immunotherapy Doubles OS in Non-Small Cell Lung Cancer Patients with Highest Levels of PD-L1 June 01, 2015Vol.38 No.05